Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
CRC incidence rates are rising among all age groups, SEER data analysis finds
Clinical Roundup

CRC incidence rates are rising among all age groups, SEER data analysis finds

November 06, 2026
Vol.52 No.41
Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Cancer History ProjectFree

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Chanock and Brawley reflect on their illustrious mentor

July 31, 2026
Vol.52 No.30
By Sara Willa Ernst
Joe Fraumeni, founder of molecular epidemiology, dies at 93
FreeObituary

Joe Fraumeni, founder of molecular epidemiology, dies at 93
“It’s hard to imagine a world without the presence of this gentle scientific giant.”

June 26, 2026
Vol.52 No.25
By Stephen J. Chanock
With five-year cancer survival at an all-time high, does this mean people are living longer?
Podcast

With five-year cancer survival at an all-time high, does this mean people are living longer?

January 21, 2026
ACS report trumpets 70% five-year survival for all cancers amid uncertain funding outlook
News Analysis

ACS report trumpets 70% five-year survival for all cancers amid uncertain funding outlook

January 16, 2026
Vol.52 No.02
By Jacquelyn Cobb and Paul Goldberg
In The Headlines: What’s up with the U.S. cancer incidence rate?
Podcast

In The Headlines: What’s up with the U.S. cancer incidence rate?

February 26, 2025
Vol.51 No.07
Trump executive order to “Make America Healthy Again” cites questionable data from Wuhan
News Analysis

Trump executive order to “Make America Healthy Again” cites questionable data from Wuhan
White House cites paper in pay-to-play journal claiming that U.S. has highest age-standardized incidence rate of cancer

February 21, 2025
Vol.51 No.07
By Paul Goldberg
ACS is using an AI-powered platform in the largest-ever population study of Black women
FreeHealth Equity

ACS is using an AI-powered platform in the largest-ever population study of Black women
Time and resources freed up from data management will go to outreach and access

August 02, 2024
Vol.50 No.31
By Jacquelyn Cobb
NCI’s SEER marks 50 years of cancer surveillance
FreeTCL Archive

NCI’s SEER marks 50 years of cancer surveillance

September 29, 2023
Vol.49 No.36
2022 Annual Report to the Nation: Overall cancer deaths continue to drop; some survival improvement in pancreatic cancer

2022 Annual Report to the Nation: Overall cancer deaths continue to drop; some survival improvement in pancreatic cancer

October 28, 2022
Vol.48 No.39
By Jacquelyn Cobb

Posts navigation

12Next

Trending Stories

  • Is it time to re-assess the practice and practicality of screening colonoscopy?
    Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives
  • In the epicenter of the measles outbreak, “love thy neighbor” does not extend to vaccination rates
    A dispatch from Lancaster County
  • From “default dead” to living the future of cancer care
    As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
  • Anthony El-Khoueiry named director of USC Norris
  • As Iowa goes blue, incoming Gov. Rob Sand and Sen. Josh Turek offer plans to address the state’s “cancer crisis”
  • Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
    Her endowed award will live on

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account